Start with the number itself, because the number is the receipt. Ten thousand steps a day did not come out of a laboratory. It came out of a 1965 product launch by Yamasa Tokei Keiki, a Japanese clock company that put a pedometer on the market and called it the Manpo-kei: man for ten thousand, po for steps, kei for meter. A ten-thousand-steps meter. The figure was chosen because it was round and easy to remember, not because anyone had measured it. It rode the fitness enthusiasm left over from the 1964 Tokyo Olympics and it sold. That is the whole origin story. I-Min Lee, the Harvard epidemiologist who later spent years actually measuring step counts against death, told Popular Science that when the device launched, "there were no actual studies that had looked at '10,000 steps,'" and that the figure stuck because "10,000 sounds good, it's easy to remember." Catrine Tudor-Locke, who runs a health-monitoring center at the University of Massachusetts Amherst and traced how the slogan spread, told CBC Radio's The Sunday Edition in 2018 that Japan was soon "manpo-kei'ing all over the place."
So the goal on your wrist is a sixty-year-old marketing target wearing a lab coat it borrowed. The interesting part is what happened when researchers finally checked the homework: the real evidence is good news, just not the news the number implies.
Take the study that motivated this piece, published in the British Journal of Sports Medicine in March 2024. Matthew Ahmadi, Emmanuel Stamatakis and colleagues fitted wrist accelerometers to more than 72,000 people in the UK Biobank and followed them for about seven years. This matters: these are measured steps, not the wishful self-reports that plague older walking research. The mortality benefit was largest somewhere between about 9,000 and 10,500 steps a day, so the slogan is not wildly off at the top end. But the same curve shows that roughly half of that maximum benefit was already banked at 4,000 to 4,500 steps. Half the payoff, at less than half the target. The curve bends early and then flattens, which is the opposite of how a goal that punishes you for stopping at 7,000 is supposed to work.
Age bends it earlier still. A 2022 meta-analysis in The Lancet Public Health, led by Amanda Paluch across fifteen international cohorts, found that in adults over 60 the risk of early death stopped falling at around 6,000 to 8,000 steps a day. More than that bought no additional longevity. In people under 60 the plateau sat higher, near 8,000 to 10,000. If you are retired, the honest target is lower than the one your grandchild's watch is nagging you toward, not higher.
And the floor is lower than almost anyone thinks. A 2023 meta-analysis in the European Journal of Preventive Cardiology, led by Maciej Banach, pooled nearly 227,000 people and found all-cause mortality risk already beginning to drop at about 3,900 steps a day. A 2025 Lancet Public Health review led by Ding Ding of the University of Sydney, covering more than 160,000 people, put the useful target at 7,000 steps, which sits comfortably inside that older-adult plateau rather than above it. Compared with a near-sedentary 2,000, seven thousand tracked with 47 percent lower mortality, and the same dose lined up with lower risk across dementia, depression, and falls. Its authors call 7,000 a more realistic goal than 10,000, and I think that is the honest headline.
One caveat, and one thing the walk-off-your-desk-job crowd gets backwards, because a former wellness copywriter does not get to hand you only the flattering figures. The caveat first: every one of these numbers is relative risk, drawn from observational cohorts. Healthier people walk more to begin with, and no amount of statistical adjustment fully separates the walking from the health that permits it. None of this is a randomized trial proving that steps cause the drop. But one question the 2024 Biobank study set out to answer directly is worth reporting exactly: it asked whether steps can offset long sedentary time, and found that they can. Even among the most sedentary participants, more steps tracked with lower mortality and cardiovascular risk, and the authors concluded that people "can and should try to offset the health consequences of unavoidable sedentary time by upping their daily step count." Walking does appear to buy back some of what the chair costs, at least in this cohort.
What survives all of that is still worth having. The dose that matters is modest, it arrives early, and for an older reader most of it is banked by 6,000 to 8,000 steps. The ten thousand was never the line between a healthy day and a lazy one. It was a good name for a pedometer. You can stop treating it as a diagnosis.
